Summary
SURMOUNT-1 (NEJM 2022): 22.5% weight loss at 72 weeks. PMID 35658024. SURMOUNT-2 in T2D, SURMOUNT-3 with intensive lifestyle, SURMOUNT-4 maintenance.
Source hierarchy
- Peer-reviewed publications in NEJM, Lancet, JAMA, Diabetes Care
- FDA prescribing information and label updates
- Clinicaltrials.gov registered trial protocols
- USP <797>, <71>, <85> pharmacy quality standards
Related clinical pages
Note for patients: Clinical trial data on this site is summarized for general education. Specific dosing decisions, contraindication assessments, and treatment plans must be made with a licensed healthcare provider who has reviewed your full medical history.
